Dimyricetin-(2'.2''') | 98840-15-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 黄酮类化合物
• 英文名称: Dimyricetin-(2'.2''')
• 英文别名: 3,5,7-Trihydroxy-2-[3,4,5-trihydroxy-2-[2,3,4-trihydroxy-6-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenyl]phenyl]chromen-4-one
• CAS: 98840-15-4
• 化学式: C₃₀H₁₈O₁₆
• 分子量: 634.463
• InChiKey: JLPXXNUOPPGOPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  46
• 可旋转键数：
  3
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  295
• 氢给体数：
  12
• 氢受体数：
  16

反应信息

• 作为反应物：
  描述：

  Dimyricetin-(2'.2''') 、 乙酸酐 在 吡啶 作用下， 以6 mg的产率得到Dimyricetin-(2'.2''')-dodecaacetat
  参考文献：
  名称：

  Chemical constituents of Baeckea frutescens leaves inhibit copper-induced low-density lipoprotein oxidation

  摘要：

  Oxidative modification of LDL plays an important role in the genesis of arteriosclerosis This study focused on the effects of the leaves of Baeckea frutescens in the prevention of arteriosclerosis The leaves of B frutescens have afforded, besides known flavonoid and chromone glycosides, a novel biflavonoid glycoside, characterized as 3-O-alpha-L-rhamnopyranosylmyricetinyl-(1-2 '',11-2 '')-3-O-alpha-L-rhamnopyranosylmyricetin on the basis of chemical and spectral evidence This compound exhibited marked inhibition of copper-induced LDL oxidation (C) 2009 Elsevier B V All rights reserved

  DOI：

  10.1016/j.fitote.2009.08.021

文献信息

• COMPOSITIONS FOR SLEEPING DISORDERS
  申请人：Chan Hsiao Chang

  公开号：US20090124627A1

  公开（公告）日：2009-05-14

  Provided herein is a method for treating, preventing, or ameliorating a disorder such as insomnia or another sleeping disorder using a composition that contains an effective amount of one or more compounds.
• US7935714B2
  申请人：——

  公开号：US7935714B2

  公开（公告）日：2011-05-03